生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

未开盘 12-11 16:00:00 EST

1,117.74

+5.87

+0.53%

最高1,121.91	最低1,110.20	成交量7.39亿
今开1,111.87	昨收1,111.87	日振幅1.05%
总市值0.00	流通市值0.00	总股本0.00
成交额158.93亿	换手率--	流通股本0.00
市净率7.03811	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1117.7389,"timestamp":1765486799999,"preClose":1111.8706,"halted":0,"volume":739414228,"delay":0,"changeRate":0.005278,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":5.868286,"latestTime":"12-11 16:00:00 EST","open":1111.8682,"high":1121.9083,"low":1110.1953,"amount":15893410084.41456,"amplitude":0.010535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765549800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.03811,"peRate":-124.516039,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139/tweets","defaultTab":"tweets","newsList":[{"id":"1111389833","title":"Genmab完成对Merus N.V.未流通普通股的要约收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1111389833","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111389833?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:11","pubTimestamp":1765523498,"startTime":"0","endTime":"0","summary":"12月12日 - Genmab A/S宣布完成对Merus N.V.未流通普通股的要约收购，并正式开始后续要约期。Genmab预计将在2027年推出Petosemtamab，并计划扩展和加速Petosemtamab的研发，未来可能拓展至其他治疗领域。Genmab相信，Petosemtamab将在2029年前能为EBITDA带来正面贡献，并具备每年十亿美元的销售潜力。94.2%的Merus股份已在Genmab的要约中被提交。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","MRUS","LU0109394709.USD","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"1131018543","title":"Anixa Biosciences公布研究性乳腺癌疫苗积极的第一阶段数据；主要终点已达成，74%的参与者观察到免疫反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1131018543","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131018543?lang=zh_cn&edition=full","pubTime":"2025-12-12 07:03","pubTimestamp":1765494239,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公布了其研究性乳腺癌疫苗的第一阶段积极数据；所有主要终点均已达成，并且在74%的参与者中观察到免疫反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"gpt_icon":0},{"id":"1148175807","title":"Rein Therapeutics：决定终止与Yorkville于7月29日签署的备用股权购买协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1148175807","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148175807?lang=zh_cn&edition=full","pubTime":"2025-12-12 06:31","pubTimestamp":1765492294,"startTime":"0","endTime":"0","summary":"Rein Therapeutics：决定终止与Yorkville于7月29日签署的备用股权购买协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1120309889","title":"精密科学、Nsabp基金会与德国乳腺组在Sabcs上发布早期三阴性乳腺癌Oncodetect® Mrd测试结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1120309889","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120309889?lang=zh_cn&edition=full","pubTime":"2025-12-12 06:30","pubTimestamp":1765492213,"startTime":"0","endTime":"0","summary":"精密科学、Nsabp基金会与德国乳腺组在Sabcs上发布早期三阴性乳腺癌Oncodetect® Mrd测试结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXAS","LU1861558580.USD","BK4585","LU2324357040.USD","BK4588","BK4139","LU1861559042.SGD","BK4548","LU0266013472.USD"],"gpt_icon":0},{"id":"1171260931","title":"REIN THERAPEUTICS INC：决定终止与Ya Ii Pn签订的7月29日预付协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1171260931","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171260931?lang=zh_cn&edition=full","pubTime":"2025-12-12 06:28","pubTimestamp":1765492092,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：决定终止与Ya Ii Pn签订的7月29日预付协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1137663344","title":"REIN THERAPEUTICS INC：因选择终止Ppa和Sepa协议未产生罚款或费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1137663344","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137663344?lang=zh_cn&edition=full","pubTime":"2025-12-12 06:28","pubTimestamp":1765492089,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC：因选择终止Ppa和Sepa协议未产生罚款或费用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"1161965582","title":"Olema Pharmaceuticals：销售协议招募书涵盖高达2亿美元普通股的发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1161965582","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161965582?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:52","pubTimestamp":1765489959,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals：销售协议招募书涵盖高达2亿美元普通股的发行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"1194394501","title":"Serina Therapeutics任命Joshua Thomas博士为化学部副总裁，进一步加强管理团队","url":"https://stock-news.laohu8.com/highlight/detail?id=1194394501","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194394501?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:18","pubTimestamp":1765487911,"startTime":"0","endTime":"0","summary":"Serina Therapeutics任命Joshua Thomas博士为化学部副总裁，进一步加强管理团队","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0},{"id":"1198326862","title":"Tenaya Therapeutics宣布迅速解决并解除对Mypeak-1™ Tn-201基因疗法I期B/II期临床试验的临床监管","url":"https://stock-news.laohu8.com/highlight/detail?id=1198326862","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198326862?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486978,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics宣布迅速解决并解除对Mypeak-1™ Tn-201基因疗法I期B/II期临床试验的临床监管","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"gpt_icon":0},{"id":"1187787927","title":"Tenaya Therapeutics Inc：首两名患者在第八周表现出强大的转导能力和Pkp2蛋白水平的显著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1187787927","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187787927?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486939,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc：首两名患者在第八周表现出强大的转导能力和Pkp2蛋白水平的显著增加","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"gpt_icon":0},{"id":"1175073936","title":"Tenaya Therapeutics Inc - 在两个患者中观察到显著的心律失常负担减少，随访超过六个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1175073936","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175073936?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486935,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc - 在两个患者中观察到显著的心律失常负担减少，随访超过六个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"gpt_icon":0},{"id":"1172114110","title":"AlphaTON Capital Corp.与Atnorth达成首个重大数据中心协议，确保瑞典2.2兆瓦高性能计算能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1172114110","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172114110?lang=zh_cn&edition=full","pubTime":"2025-12-12 03:45","pubTimestamp":1765482309,"startTime":"0","endTime":"0","summary":"AlphaTON Capital Corp.与Atnorth达成首个重大数据中心协议，确保瑞典2.2兆瓦高性能计算能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATON"],"gpt_icon":0},{"id":"1151282268","title":"Celcuity在2025年圣安东尼奥乳腺癌研讨会上展示Pik3CA野生型队列的Viktoria-1三期试验更新结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1151282268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151282268?lang=zh_cn&edition=full","pubTime":"2025-12-12 03:35","pubTimestamp":1765481711,"startTime":"0","endTime":"0","summary":"Celcuity在2025年圣安东尼奥乳腺癌研讨会上展示Pik3CA野生型队列的Viktoria-1三期试验更新结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1148610518","title":"凯信远达 - 投资用于资助中国阶段1肾移植抗体介导排斥反应研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1148610518","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148610518?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:12","pubTimestamp":1765462338,"startTime":"0","endTime":"0","summary":"凯信远达 - 投资用于资助中国阶段1肾移植抗体介导排斥反应研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"1166602535","title":"Rezolute高管表示，因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1166602535","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166602535?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:11","pubTimestamp":1765462283,"startTime":"0","endTime":"0","summary":"Rezolute高管表示，因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1151710553","title":"MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine，作为晚期非小细胞肺癌的三线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1151710553","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151710553?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:02","pubTimestamp":1765461732,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine，作为晚期非小细胞肺癌的三线治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"1136341643","title":"Rezolute高管表示，63名参与者中有四名因不良事件早期终止研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1136341643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136341643?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:54","pubTimestamp":1765461255,"startTime":"0","endTime":"0","summary":"Rezolute高管表示，63名参与者中有四名患者因不良事件早期终止了研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1164504881","title":"杰龙股价盘前上涨2.3%；公司宣布战略重组计划，全员裁减三分之一","url":"https://stock-news.laohu8.com/highlight/detail?id=1164504881","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164504881?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:10","pubTimestamp":1765458621,"startTime":"0","endTime":"0","summary":"杰龙股价盘前上涨2.3%；公司宣布战略重组计划，全员裁减三分之一","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GERN"],"gpt_icon":0},{"id":"1189846262","title":"Absci公布新的人体外数据，显示Abs-201™能刺激毛发生长并再生干细胞微环境，可能逆转毛囊微型化","url":"https://stock-news.laohu8.com/highlight/detail?id=1189846262","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189846262?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:09","pubTimestamp":1765458596,"startTime":"0","endTime":"0","summary":"Absci公布新的人体外数据，显示Abs-201™能刺激毛发生长并再生干细胞微环境，可能逆转毛囊微型化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABSI","BK4139","BK4539"],"gpt_icon":0},{"id":"1104472090","title":"Savara宣布欧洲专利局计划授予Molbreevi液体制剂专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1104472090","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104472090?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:06","pubTimestamp":1765458399,"startTime":"0","endTime":"0","summary":"Savara宣布欧洲专利局计划授予Molbreevi液体制剂专利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.1345},{"period":"ytd","weight":0.1759}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}